Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
Danese S, Bonovas S, Lopez A, Fiorino G, Sandborn WJ, Rubin DT, Kamm MA, Colombel JF, Sands BE, Vermeire S, Panes J, Rogler G, D'Haens G, Peyrin-Biroulet L.
Danese S, et al. Among authors: rubin dt.
Gastroenterology. 2018 Jul;155(1):76-87. doi: 10.1053/j.gastro.2018.03.032. Epub 2018 Mar 28.
Gastroenterology. 2018.
PMID: 29601825
Review.